These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 25079452)
21. Hormone replacement therapy: will it affect seizure control and AED levels? Harden CL Seizure; 2008 Mar; 17(2):176-80. PubMed ID: 18187348 [TBL] [Abstract][Full Text] [Related]
22. Epilepsy, sex hormones, and antiepileptic drugs. Mattson RH; Cramer JA Epilepsia; 1985; 26 Suppl 1():S40-51. PubMed ID: 3158512 [TBL] [Abstract][Full Text] [Related]
23. Delivery of a Personalized Treatment Approach to Women with Epilepsy. Voinescu PE; Pennell PB Semin Neurol; 2017 Dec; 37(6):611-623. PubMed ID: 29270934 [TBL] [Abstract][Full Text] [Related]
24. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Yerby MS Neurology; 2000; 55(5 Suppl 1):S21-31; discussion S54-8. PubMed ID: 11001359 [TBL] [Abstract][Full Text] [Related]
25. Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing? Palmieri C; Canger R CNS Drugs; 2002; 16(11):755-64. PubMed ID: 12383031 [TBL] [Abstract][Full Text] [Related]
26. Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial. Herzog AG Seizure; 2015 May; 28():18-25. PubMed ID: 25770028 [TBL] [Abstract][Full Text] [Related]
27. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Morrell MJ Epilepsia; 1996; 37 Suppl 6():S34-44. PubMed ID: 8941040 [TBL] [Abstract][Full Text] [Related]
28. Three patterns of catamenial epilepsy. Herzog AG; Klein P; Ransil BJ Epilepsia; 1997 Oct; 38(10):1082-8. PubMed ID: 9579954 [TBL] [Abstract][Full Text] [Related]
29. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. McAuley JW; Anderson GD Clin Pharmacokinet; 2002; 41(8):559-79. PubMed ID: 12102641 [TBL] [Abstract][Full Text] [Related]
36. Implications of hormonal and neuroendocrine changes associated with seizures and antiepileptic drugs: a clinical perspective. Pack AM Epilepsia; 2010 Jul; 51 Suppl 3():150-3. PubMed ID: 20618422 [TBL] [Abstract][Full Text] [Related]
37. Gender-specific challenges in the management of epilepsy in women. Noe KH Semin Neurol; 2007 Sep; 27(4):331-9. PubMed ID: 17701870 [TBL] [Abstract][Full Text] [Related]
38. Maximizing the health of women with epilepsy: science and ethics in new drug development. Morrell MJ Epilepsia; 1997; 38 Suppl 4():S32-41. PubMed ID: 9240239 [TBL] [Abstract][Full Text] [Related]
39. Women and epilepsy: review and practical recommendations. Røste LS; Taubøll E Expert Rev Neurother; 2007 Mar; 7(3):289-300. PubMed ID: 17341177 [TBL] [Abstract][Full Text] [Related]
40. Which information on women's issues in epilepsy does a community pharmacist need to know? A Delphi consensus study. Shawahna R Epilepsy Behav; 2017 Dec; 77():79-89. PubMed ID: 29127865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]